3 Fast Growing ASX Stocks With High Insider Ownership to Watch

Fast growing stocks with high insider ownership can be especially interesting when inflation trends, interest rate expectations and geopolitical tensions are all pulling markets in different directions. With investors watching oil prices, bond yields and earnings reports so closely, this screener focuses on companies where growth is a key part of the story and management has significant skin in the game. That combination can appeal if you want exposure to growth, but also care about alignment between insiders and outside shareholders. In this article, you will see 3 stocks from the Fast Growing Stocks With High Insider Ownership list.

Predictive Discovery (ASX:PDI)

Overview: Predictive Discovery is a West Africa focused gold company centred on the large Bankan Gold project in Guinea, working to convert its resource base into an operating gold hub alongside existing production in the region.

Market Cap: A$3.45b

Predictive Discovery catches attention because it sits on a sizeable 9.5 million ounce resource and 4.5 million ounce reserve base while still reporting losses and minimal current revenue. As a result, much of the story is about what could be built from here. The merger with Robex and ramp up at Kiniero give the group two producing mines and cash flow that is already being used to progress Bankan. This structure may appeal if you want growth tied to tangible assets rather than early stage concepts. At the same time, short cash runway, high P/B, permitting risk in Guinea and operational risk in Mali mean the upside case is closely linked to execution and funding outcomes you will want to examine in more detail.

Predictive Discovery is working to turn a 9.5 million ounce resource into a multi mine gold hub. However, the central focus is how funding, reserves and cash flow fit together in the 2 key rewards and 4 important warning signs (2 are major!)

Telix Pharmaceuticals (ASX:TLX)

Overview: Telix Pharmaceuticals develops and sells radiopharmaceutical products that help doctors both find and treat cancers, using targeted imaging agents and therapies for prostate, kidney and brain tumours, as well as a growing manufacturing and distribution platform across several countries.

Operations: Telix generates most of its revenue from Precision Medicine at about US$621.9m, with Manufacturing Solutions contributing US$245.1m and Therapeutics US$9.3m, partially offset by US$72.5m of inter-segment eliminations.

Market Cap: A$5.52b

Telix Pharmaceuticals sits at an interesting crossroads for growth-focused investors, with a commercial imaging franchise already generating hundreds of millions in sales and a late stage cancer therapy pipeline that could reshape its earnings profile if trials such as ProstACT Global and IPAX BrIGHT are successful. The current loss making position and reliance on external funding keep risk on the table, alongside regulatory issues such as FDA Complete Response Letters and an SEC subpoena over pipeline disclosures. At the same time, revenue guidance close to US$1b, an experienced and independent board, and P/S metrics below many peers suggest the market is still debating how to value that mix of existing cash flow and potential new therapies rather than fully pricing it in.

Telix Pharmaceuticals already has hundreds of millions in revenue. However, the real inflection may lie in how its late stage cancer programs reshape the story. Get the full picture in the analyst forecasts for Telix Pharmaceuticals

Lindian Resources (ASX:LIN)

Overview: Lindian Resources is a Perth based explorer focused on rare earths, bauxite and gold, with its flagship Kangankunde Rare Earths project in Malawi and additional exploration interests across Tanzania, Guinea, Malawi, Australia and Singapore.

Market Cap: A$1.49b

Lindian Resources is attracting attention because Kangankunde is moving from concept into early mining activity, with first production targeted for Q4 2026 and recent news of the first blast, ore haulage and stockpile build all pointing to tangible progress. For growth oriented investors, forecasts for very rapid earnings and revenue expansion sit alongside high risk markers, including continued losses, heavy reliance on external borrowing, substantial recent dilution and an inexperienced, non independent board and management team. The company has also been reshaping its commercial set up by ending a monazite sale agreement and building its own Singapore marketing hub, which may appeal if you are looking for early stage exposure to rare earths but are prepared to weigh execution and funding risk carefully against that potential.

Lindian Resources is moving fast from first blast to potential rare earths producer. Yet the real story sits in how early cash flows, funding needs and execution risk connect in the analyst forecasts for Lindian Resources

The 3 stocks in this article are only a starting point, with the full Simply Wall St Fast Growing Stocks With High Insider Ownership screener surfacing 100 more companies that pair rapid growth with high insider alignment in ways that may surprise you in the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter to you so you can focus on the highest conviction growth ideas where both analysts and management see meaningful potential.

Take Control of Your Investment Journey

If Telix Pharmaceuticals or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Breakout ideas rarely stay quiet for long, and the strongest stories often gain momentum before most investors notice. Scan these fresh stock shortlists while it matters and get in early.

• Spot companies with resilient balance sheets before the crowd by running the list of solid balance sheet and fundamentals (20 results) that highlights businesses built to handle shocks while still pursuing growth.
• Explore potential opportunities in precious metals by reviewing the curated 33 elite gold producer stocks that filters producers with scale, quality assets and cleaner financial profiles.
• Review long term infrastructure themes by checking the hand picked 34 power grid technology and infrastructure stocks capturing companies tied to grid upgrades and electricity demand trends.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com